Login / Signup

Consideration with "Intratumoral gene therapy versus intravenous gene therapy for distant metastasis control with DDMC non-viral vector-p53".

Y OnishiP ZarogoulidisRui-Cheng JiM OnishiN KubotaY Eshita
Published in: Gene therapy (2021)
Keyphrases
  • gene therapy
  • sars cov
  • lymph node
  • high dose
  • low dose
  • free survival